Computational studies on the interaction of Omicron subvariants (BA.1, BA.2, and BA.3) with ACE2 and polyphenols

© 2023 John Wiley & Sons Ltd..

INTRODUCTION: The SARS-CoV-2 Omicron variant BA.2 is spreading widely across the globe. The World Health Organization (WHO) designated BA.2 as a variant of concern due to its high transmission rate and pathogenicity. To elucidate the structural changes caused by mutations, we conducted a comparative analysis of BA.2 with variants BA.1 and BA.3.

OBJECTIVE: In the present study, we aimed to investigate the interactions of the spike glycoprotein receptor-binding domain (SGp RBD) of Omicron variants BA.1, BA.2, and BA.3 with the human receptor hACE2. Further, a library of 233 polyphenols was screened by molecular docking with the SGp RBDs of Omicron variants BA.1, BA.2, and BA.3.

METHODS: Protein-protein and protein-ligand molecular docking simulations were performed with AutoDock Vina and the ClusPro 2.0 server, respectively. The protein-ligand interactions were evaluated by BIOVIA Discovery Studio and ChimeraX 1.4. The molecular dynamics simulations for 100 ns were performed using GROMACS 2021.

RESULTS: Compared to other variants of concern, the structural changes in Omicron caused by mutations at key positions improved its ability to cause infection. Despite multiple mutations, many important polyphenols bind effectively at the RBDs of Omicron variants, with the required pharmacokinetic and ADME features and obeying the Lipinski rule.

CONCLUSION: Even though Omicron variants have multiple mutations and their transmission rate is relatively high, the computed binding affinities of lead polyphenols like epigallocatechin-3-O-gallate (EGCG) and luteolin-7-O-glucuronide (L7G) indicate that traditional medicines and proper immunity booster diets may be useful in the long-term fight against SARS-CoV-2.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:34

Enthalten in:

Phytochemical analysis : PCA - 34(2023), 7 vom: 27. Okt., Seite 800-815

Sprache:

Englisch

Beteiligte Personen:

Vardhan, Seshu [VerfasserIn]
Sahoo, Suban K [VerfasserIn]

Links:

Volltext

Themen:

ACE2 protein, human
Angiotensin-Converting Enzyme 2
Dynamics simulations
EC 3.4.17.23
Journal Article
Ligands
Molecular docking
Omicron
Polyphenols

Anmerkungen:

Date Completed 06.11.2023

Date Revised 06.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/pca.3204

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM351175423